CA-103

N/A

Report date: 2024/12/12 10:42:59

Base Information

Drug NameCA-103
Drug Alias NameCA103CA-103
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsAndrogen Receptor antagonists
TargetsSerine/threonine-protein kinase mTORAndrogen Receptor
Therapy Area/IndicationsProstatic HyperplasiaProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCurigin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCurigin Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic HyperplasiaProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A